Quantitative Norms for Lipid Intake: Energy Contribution, Minimum Threshold, and Distribution in the Diet

Last updated: May 21, 2026 Русский

Introduction

Lipids – a broad category that includes triacylglycerols (fats and oils), phospholipids, and sterols – are indispensable macronutrients. Unlike proteins and carbohydrates, which have clearly defined average requirements (AR) and population reference intakes (PRI) for specific physiological functions, dietary fats present a unique challenge for quantitative recommendations (EFSA, 2010). While the human body requires two essential fatty acids (linoleic and α-linolenic acid), it can synthesise all other fatty acids endogenously. Consequently, dietary reference values (DRVs) for total fat are not expressed as a single fixed number but as a range of energy percentages (E%), bounded by a lower threshold to prevent nutritional inadequacies and an upper threshold to limit excess energy intake (Nordic Council of Ministers, 2023; WHO, 2023).

Over the past three decades, the scientific understanding of dietary fat has shifted. Early guidelines, such as those from the 1980s, primarily focused on reducing total fat intake to lower the risk of chronic diseases. Today, international health authorities agree that the quality of fat (i.e., its fatty acid profile) is at least as important as the quantity. Nevertheless, quantifying the appropriate proportion of total energy from fat remains a critical component of food-based dietary guidelines (FBDGs) and public health policy (Herforth et al., 2019; Schwingshackl et al., 2021). The question is not merely `how much` but `within which boundaries` – too little fat impairs absorption of fat-soluble vitamins and may compromise essential fatty acid status, while excessive fat intake, particularly when coupled with a sedentary lifestyle, can contribute to positive energy balance and unhealthy weight gain (Hooper et al., 2020; WHO, 2023).

Several authoritative bodies have issued quantitative recommendations for total fat intake. The European Food Safety Authority (EFSA) proposed a reference intake range of 20–35 E% for adults, based on observed intakes in European populations and the need to maintain a favourable blood lipid profile (EFSA, 2010). The Nordic Nutrition Recommendations (NNR2023) suggest a slightly broader range of 25–40 E%, acknowledging higher physical activity levels and cultural dietary patterns in Nordic countries (Retterstøl & Rosqvist, 2024; Rosqvist & Niinistö, 2024). In contrast, the World Health Organization (WHO), in its 2023 guideline, issued a conditional recommendation that adults limit total fat intake to ≤30 E% for the primary prevention of unhealthy weight gain, emphasising that the evidence is based primarily on randomised controlled trials of body fatness rather than on cardiovascular endpoints (WHO, 2023).

Importantly, these quantitative norms are not uniform across all age groups. Infants and young children have higher relative fat requirements to support rapid brain development and growth, with recommended intakes of 30–45 E% during the complementary feeding period (6–11 months), gradually decreasing to adult levels by late adolescence (EFSA, 2010; Nordic Council of Ministers, 2023). Moreover, the distribution of total fat across different fatty acid classes – saturated (SFA), monounsaturated (MUFA), polyunsaturated (PUFA), and trans (TFA) – is intrinsically linked to the overall energy budget, as the sum of their contributions cannot exceed total fat intake (Sacks et al., 2017; Lovegrove, 2025).

This article provides a systematic educational overview of the quantitative norms for dietary lipids, focusing on three core aspects: (i) the energy contribution of fats (expressed as E%), (ii) the minimum threshold required to prevent functional deficiencies, and (iii) the distribution of these recommendations across different life stages. We will draw primarily on the dietary reference value frameworks established by EFSA (2010), the Nordic Nutrition Recommendations 2023, and the WHO (2023) guideline on total fat intake. The discussion will remain strictly within the domain of macronutrient physiology and nutritional epidemiology, without venturing into clinical therapy, disease-specific guidelines, or unresolved scientific controversies.

1. The Concept of Dietary Reference Values for Macronutrients

To understand quantitative norms for lipid intake, it is essential first to clarify what dietary reference values (DRVs) represent and how they apply to macronutrients, which differ fundamentally from micronutrients in their physiological roles and assessment methodologies.

1.1. Distinction Between Micronutrient and Macronutrient Reference Values

For vitamins and minerals, DRVs are typically derived from dose–response studies or factorial models that identify an Average Requirement (AR) – the intake level sufficient to meet the needs of half the healthy individuals in a life-stage group. The Recommended Intake (RI) is then calculated as AR plus two standard deviations (assuming a normal distribution), covering approximately 97.5% of the population (Christensen et al., 2020; Nordic Council of Ministers, 2023). This approach works well for nutrients with established deficiency syndromes and quantifiable biomarkers of status.

Macronutrients – fats, carbohydrates, and proteins – present a different picture. They are primarily energy sources, and the body can metabolically adapt to a wide range of intakes without manifesting classical deficiency symptoms, except for the two essential fatty acids (linoleic and α‑linolenic acid) and certain amino acids. Consequently, for total fat, no Average Requirement or Recommended Intake can be defined in the traditional sense (EFSA, 2010). Instead, DRVs for total fat are expressed as a Reference Intake Range (a lower and upper bound of energy percentage), while for some specific fatty acids, Adequate Intakes (AIs) are proposed based on observed intakes in healthy populations where deficiency is absent (Nordic Council of Ministers, 2023).

1.2. Definition of Key Terms Used for Macronutrient Recommendations

To avoid confusion, the following definitions, adapted from EFSA (2010) and the Nordic Nutrition Recommendations 2023 (Christensen et al., 2020), are used throughout this article:

  • Reference Intake Range (for total fat): A range of intakes expressed as a percentage of total energy (E%) that is compatible with good health and nutritional adequacy in practically all individuals of a population group. Intakes below the lower bound increase the risk of inadequacy (e.g., of essential fatty acids or fat-soluble vitamins); intakes above the upper bound may increase the risk of chronic diseases (e.g., unhealthy weight gain).
  • Adequate Intake (AI): A recommended average daily intake level based on observed or experimentally determined approximations of nutrient intake by a group of healthy people. For fatty acids such as linoleic acid (LA) and α‑linolenic acid (ALA), AIs are used when an AR cannot be established. The AI is expected to meet or exceed the needs of most individuals (EFSA, 2010; Nordic Council of Ministers, 2023).
  • Average Requirement (AR): Not applicable to total fat. However, for illustrative purposes in macronutrient physiology, the AR concept is sometimes used for protein and certain fatty acids. For lipids, the closest equivalent is the physiological requirement for essential fatty acids to prevent deficiency signs (e.g., triene:tetraene ratio >0.4), but no formal AR has been derived for total fat (EFSA, 2010).
  • Tolerable Upper Intake Level (UL): The maximum daily intake unlikely to cause adverse health effects. For total fat, no UL has been set because adverse effects are not directly related to fat itself but to excess energy intake when fat displaces other macronutrients or when fat intake contributes to energy imbalance. For individual saturated and trans fatty acids, the principle is that intakes should be “as low as possible within a nutritionally adequate diet” rather than a specific UL (EFSA, 2010; Nordic Council of Ministers, 2023).

1.3. Why Total Fat Recommendations Are Expressed as Energy Percentage (E%)

Expressing fat intake as a percentage of total energy (E%) rather than absolute grams per day serves two critical purposes. First, it accounts for variations in energy expenditure due to age, sex, physical activity level (PAL), and body size. An individual with a high energy requirement (e.g., a physically active young male) can consume more grams of fat while staying within the same E% range as a sedentary elderly woman. Second, the E% approach allows for flexible integration with recommendations for other macronutrients (carbohydrates and proteins), as the three must sum to 100% of energy intake (excluding alcohol) (EFSA, 2010).

For example, the reference energy intake for an adult with a PAL of 1.6 (moderately active) is approximately 9–10 MJ/day (≈2150–2400 kcal/day). A fat intake of 30 E% would correspond to approximately 65–80 g of fat per day. In contrast, for a pregnant woman in her third trimester with a higher energy requirement (≈11.4 MJ/day, ∼2725 kcal/day), the same 30 E% translates to about 90 g of fat per day (Nordic Council of Ministers, 2023, Appendix 4).

1.4. The Role of Physical Activity Level (PAL) in Setting Reference Values for Fat

Energy expenditure directly influences the absolute amount of fat that can be consumed within a given E% range. The Nordic Nutrition Recommendations 2023 use three standard PAL values for calculating energy requirements (Nordic Council of Ministers, 2023; Cloetens & Ellegård, 2023):

  • PAL 1.4 – Low active: Sedentary work, little or no leisure-time physical activity.
  • PAL 1.6 – Average active: Sedentary work with some additional physical activity (e.g., walking 30–60 minutes daily).
  • PAL 1.8 – High active: Physically active work or regular vigorous leisure-time activity.

For adults aged 18–50 years with an average PAL of 1.6, the estimated total energy requirement is approximately 9.0–11.3 MJ/day (females and males, respectively). For planning purposes, a total fat intake of 32–33 E% (the midpoint of the NNR2023 range) is often used as a population target (Retterstøl & Rosqvist, 2024). However, it is important to emphasise that these are group-level reference values; individual requirements may differ.

1.5. Why No Average Requirement (AR) for Total Fat Exists

The absence of an AR for total fat is not a methodological gap but a reflection of biological principles. Unlike iron or calcium, where balance studies can identify intake levels needed to replace obligatory losses, the body has a large capacity to synthesise fatty acids from carbohydrates and to store them in adipose tissue. The only known absolute dietary requirement for fat is the provision of the two essential polyunsaturated fatty acids – linoleic acid (n‑6) and α‑linolenic acid (n‑3). The EFSA Panel concluded that “there are insufficient data to determine the absolute amounts of fat and individual fatty acids needed for metabolic integrity” beyond these essential fatty acids (EFSA, 2010, p. 32). Consequently, the lower bound of the reference intake range (20 E%) is derived not from a specific deficiency endpoint but from the lowest observed intake levels in European populations that are not associated with overt signs of nutritional inadequacy (EFSA, 2010; Nordic Council of Ministers, 2023).

Similarly, the upper bound is informed by evidence linking high-fat diets (especially when combined with low physical activity) to higher energy intake and subsequent body fatness, but no dose–response threshold for harm can be identified that would justify a classical UL (WHO, 2023). Hence, the quantitative norms for total fat are framed as a range with practical and physiological justifications rather than as a precise requirement.

This conceptual framework – ranges, AIs, and conditional recommendations – provides the foundation for the specific quantitative values discussed in the following sections.

2. Energy Contribution (E%) and the Upper Bound of Fat Intake

The most frequently asked question regarding dietary fat is: What is the maximum proportion of total energy that should come from fat? The answer, however, is not a single number but a range that varies across authoritative guidelines depending on the primary endpoint considered – whether lipid profile, body weight maintenance, or overall dietary patterns.

2.1. Historical Evolution of Total Fat Recommendations

In the 1980s and 1990s, many national guidelines recommended that total fat intake not exceed 30% of total energy (E%), driven largely by the diet‑heart hypothesis and concerns about obesity. The underlying rationale was that lowering total fat would automatically lower saturated fat and cholesterol, thereby reducing cardiovascular risk (Herforth et al., 2019; Sacks et al., 2017). However, accumulating evidence from large randomised controlled trials, such as the Women’s Health Initiative, showed that reducing total fat without attention to fat quality had little effect on cardiovascular outcomes (Sacks et al., 2017). Consequently, the emphasis shifted from merely restricting total fat to replacing saturated and trans fats with unsaturated fats while maintaining total fat within a moderate range.

By the early 2000s, the Institute of Medicine (IOM) in the United States had introduced the concept of Acceptable Macronutrient Distribution Ranges (AMDRs), setting total fat at 20–35 E% for adults (as cited in EFSA, 2010). European and Nordic authorities followed with similar but not identical ranges.

2.2. Current Quantitative Ranges from Major Authorities

Table 1 summarises the upper bounds proposed by three key international bodies. A more detailed discussion follows.

Table. Upper bounds of total fat intake recommended by EFSA, NNR2023, and WHO.

Authority Upper bound (E%) Target population Primary rationale
EFSA (2010) 35% Adults (≥18 years) Maintenance of favourable blood lipid profile; avoidance of excess energy intake
Nordic Council of Ministers (NNR2023) 40% (range 25–40%) Adults (≥18 years) Higher physical activity levels in Nordic populations; flexibility for active individuals
WHO (2023) 30% (conditional) Adults (≥20 years) Prevention of unhealthy weight gain (primary endpoint: body fatness)

EFSA (2010): 35% as an Upper Bound

The European Food Safety Authority proposed a reference intake range of 20–35 E% for total fat for adults (EFSA, 2010). The upper bound of 35% was selected based on several converging lines of evidence:

  • At intakes above 35 E%, there is a tendency for higher total fat intake to be associated with higher energy intake and, over time, greater body fatness, particularly in sedentary populations (EFSA, 2010, Section 5.7).
  • High-fat diets (typically >35–40 E%) may decrease insulin sensitivity compared to lower-fat diets under controlled conditions, although the evidence is not entirely consistent.
  • Practically, 35 E% is achievable within a balanced diet that provides adequate carbohydrate and protein while limiting saturated fatty acids to below 10 E% (EFSA, 2010).

EFSA noted that total fat intakes exceeding 35 E% “may be compatible with both good health and normal body weight depending on dietary patterns and the level of physical activity” (EFSA, 2010, p. 51). Thus, the 35% value is not a strict toxicological threshold but a practical guide for population-level dietary planning.

Nordic Nutrition Recommendations 2023: 40% as an Upper Bound

The Nordic Nutrition Recommendations 2023 (NNR2023) set a wider reference intake range of 25–40 E% for adults (Retterstøl & Rosqvist, 2024; Rosqvist & Niinistö, 2024). The higher upper bound of 40% reflects several region-specific considerations:

  • Higher habitual physical activity: Nordic populations generally have higher average physical activity levels (PAL 1.6–1.8) compared to many other European regions. Active individuals can consume a higher fat percentage without exceeding energy requirements (Nordic Council of Ministers, 2023, Appendix 4).
  • Fat quality focus: The NNR2023 places strong emphasis on replacing saturated with unsaturated fats rather than strictly limiting total fat. Within a diet rich in unsaturated vegetable oils, nuts, seeds, and fatty fish, total fat can reach 40 E% while maintaining a favourable fatty acid profile (Retterstøl & Rosqvist, 2024).
  • Practical dietary patterns: A total fat intake of 25–40 E% aligns with the observed fat consumption in Nordic countries (34–39 E% in recent surveys) and allows for culturally acceptable meal patterns that include moderate amounts of dairy, meat, and fish (Lemming & Pitsi, 2022, as cited in Nordic Council of Ministers, 2023).

The NNR2023 committee explicitly states that for individuals with low physical activity or those prone to weight gain, a lower total fat intake (closer to 25–30 E%) may be more appropriate. Conversely, for very active individuals, intakes above 40 E% can be compatible with good health (Nordic Council of Ministers, 2023).

WHO (2023): A Conditional Recommendation of ≤30 E%

In 2023, the World Health Organization issued a conditional recommendation that adults limit total fat intake to 30% of total energy or less for the primary prevention of unhealthy weight gain (WHO, 2023). This recommendation is based on a systematic review of randomised controlled trials (RCTs) in which weight loss was not an explicit goal (Hooper et al., 2020).

Key findings from the evidence synthesis (WHO, 2023):

  • Reducing total fat intake led to lower body weight, body mass index (BMI), waist circumference, and percentage body fat (high certainty evidence).
  • A dose–response relationship was observed: greater reductions in fat intake were associated with greater differences in body weight.
  • When trials were subgrouped by achieved total fat intake, those reaching ≤30 E% showed a greater difference in body weight (MD –1.55 kg) compared to those not reaching this target (MD –0.90 kg) (WHO, 2023, Annex 6).

The recommendation is classified as conditional (rather than strong) for several reasons. First, some individuals who reduce fat intake might replace the energy with foods undesirable from a dietary quality perspective (e.g., free sugars), reducing net benefit. Second, the evidence applies primarily to the prevention of weight gain, not to weight loss or management of established obesity. Third, there is variability in how different populations respond to fat reduction depending on baseline dietary patterns and physical activity levels (WHO, 2023, Evidence to Recommendation section).

Notably, the WHO recommendation explicitly acknowledges that individuals who can maintain energy balance at higher fat intakes may not need to restrict total fat to ≤30 E%. The recommendation is intended for population-level guidance, not as a strict individual prescription.

2.3. Why Upper Bounds Differ: Endpoints and Context

The differences between the 35%, 40%, and 30% upper bounds reflect different primary endpoints and target populations:

  • EFSA (35%): Focuses on blood lipid profile and prevention of excess energy intake in a general European population with moderate physical activity.
  • NNR2023 (40%): Prioritises flexibility for active Nordic populations and emphasises fat quality over fat quantity.
  • WHO (30%): Prioritises prevention of unhealthy weight gain, using body fatness as the primary outcome, and applies to a global audience including populations with rising obesity rates.

These differences are not contradictions but rather complementary views. For a sedentary individual in an obesogenic environment, a lower upper bound (30%) may be prudent. For a physically active person with a healthy body weight, a higher bound (35–40%) is entirely compatible with good health.

2.4. Energy Density and Passive Overconsumption

An important mechanistic justification for an upper bound on total fat is the concept of energy density and passive overconsumption. Fats provide approximately 37 kJ/g (9 kcal/g), more than twice the energy density of carbohydrates or proteins (≈17 kJ/g or 4 kcal/g). Diets high in fat tend to have higher energy density, and evidence suggests that consuming high–energy‑density diets can undermine normal appetite regulation, leading to increased overall energy intake through passive overconsumption (WHO, 2003, as cited in EFSA, 2010; WHO, 2023).

Controlled feeding studies have shown that when participants are offered isoenergetically dense diets differing in fat content, those on higher‑fat diets consume more energy ad libitum without reporting greater satiety (EFSA, 2010, Section 5.7). This effect is particularly relevant in sedentary populations where energy expenditure is low, and small daily energy imbalances can accumulate over years into significant weight gain.

However, the effect of fat on energy balance is not independent of the food matrix and overall dietary pattern. For example, nuts and seeds are energy‑dense but are not consistently associated with weight gain in prospective cohorts, likely due to their high satiety value and incomplete energy absorption (Rosqvist & Niinistö, 2024; Retterstøl & Rosqvist, 2024). Therefore, the upper bound on total fat should be interpreted within the context of overall diet quality.

2.5. Implications of the Upper Bound for Dietary Planning

For practical dietary planning, a total fat intake of approximately 32–33 E% is often used as a target (the midpoint of the NNR2023 range). This value ensures that:

  • At least two‑thirds of fatty acids come from unsaturated sources (MUFA and PUFA) when saturated fat is kept below 10 E%.
  • There is sufficient room for carbohydrate intake (45–60 E%) and protein (10–20 E%) within a 100% energy budget.
  • The diet remains palatable and culturally acceptable in most European and North American contexts (Nordic Council of Ministers, 2023).

It is also important to recognise that the upper bound is not a target to be achieved by increasing fat intake in individuals who already consume less than the recommended range. For populations where undernutrition is a concern, maintaining or even increasing total fat intake (in line with guidance on fat quality) may be important to achieve adequate energy intake (WHO, 2023, Remarks for recommendation 1).

In summary, the upper bound of total fat intake – whether 30, 35, or 40 E% – is not a universal threshold beyond which harm inevitably occurs. Rather, it is a population‑level guide that should be adjusted for individual physical activity, body weight status, and overall dietary quality. The next section examines the lower bound of fat intake, which addresses the opposite risk: that of nutritional inadequacy.

3. The Lower Threshold of Fat Intake: Why It Is Necessary

While much public health attention focuses on limiting high fat intakes, the opposite concern – consuming too little fat – is equally important from a nutritional physiology perspective. Unlike carbohydrates, for which no absolute lower bound exists (the body can synthesise glucose from other substrates), dietary fats provide two essential nutrients that cannot be synthesised endogenously: linoleic acid (LA, 18:2n‑6) and α‑linolenic acid (ALA, 18:3n‑3). Moreover, fats are indispensable for the absorption of fat‑soluble vitamins (A, D, E, and K) and for maintaining normal energy homeostasis, particularly in growing children and physically active individuals.

3.1. Physiological Rationale for a Lower Threshold

The lower bound of total fat intake is not derived from a classical deficiency endpoint but from the need to prevent functional inadequacies in three interconnected areas:

1. Provision of essential polyunsaturated fatty acids (PUFA). Linoleic acid (n‑6) and α‑linolenic acid (n‑3) are classified as essential because humans lack the Δ12 and Δ15 desaturases required to introduce double bonds at the n‑6 and n‑3 positions (EFSA, 2010). Overt deficiency of linoleic acid is rare in free‑living populations but has been documented in patients receiving fat‑free parenteral nutrition. Clinical signs include dry, scaly skin, poor wound healing, and growth retardation in infants; these symptoms reverse when linoleic acid is provided at approximately 1–2 E% (EFSA, 2010, Section 5.1.2.1). For α‑linolenic acid, deficiency signs (neurological abnormalities) have been described at extremely low intakes (< 0.2 E%), although such deficiencies are exceptionally uncommon in the general population (Holman et al., 1982, as cited in EFSA, 2010).

2. Absorption of fat‑soluble vitamins (A, D, E, K) and carotenoids. The absorption of these lipophilic compounds requires the presence of dietary fat in the intestinal lumen to form mixed micelles. Very low‑fat meals or long‑term very low‑fat diets (typically below 10–15 g fat per meal, or below 15–20 E% total fat) significantly impair the absorption of vitamin A, vitamin E, and β‑carotene, and may compromise vitamin K and vitamin D status (EFSA, 2010). For example, adding only 5 g of fat to a very low‑fat meal (5 g fat) substantially improved vitamin A bioavailability (Jayarajan et al., 1980, as cited in EFSA, 2010).

3. Energy density and growth in early life. Infants and young children have high energy requirements relative to their small stomach capacity. Human milk provides approximately 50–55 E% from fat, reflecting the need for energy‑dense nutrition during the period of rapid brain development and growth (Nordic Council of Ministers, 2023). Complementary feeding diets that fall below approximately 25 E% fat have been associated with inadequate intake of fat‑soluble vitamins and, in some studies, lower energy intake and reduced growth velocity (EFSA, 2010, Section 5.1.1.4).

3.2. Quantitative Lower Bounds in International Guidelines

Different authorities have proposed lower thresholds ranging from 15 to 25 E% depending on age group and physiological context.

EFSA (2010): 20 E% for Adults

The European Food Safety Authority set the lower bound of the reference intake range for total fat at 20 E% for adults (EFSA, 2010). This value was selected on the following grounds:

  • Among European populations, the lowest observed total fat intakes (around 20 E%) are not associated with overt signs of essential fatty acid deficiency or vitamin insufficiency.
  • Below 20 E%, there is a progressive risk of inadequate intake of linoleic acid and α‑linolenic acid, especially in populations where the quality of dietary fat is poor (e.g., high saturated fat, low PUFA).
  • Very low‑fat diets (≈15 E% or lower) tend to lower HDL cholesterol and increase triglycerides in susceptible individuals, although these changes were not considered sufficient to define a strict requirement (EFSA, 2010, Section 5.2.1).

EFSA also noted that for pregnant and lactating women, who have higher energy requirements, the same 20 E% lower bound applies in relative terms, although absolute fat intake (in grams) will be higher due to increased energy needs (EFSA, 2010).

Nordic Nutrition Recommendations 2023 (NNR2023): Age‑Dependent Lower Bounds

The NNR2023 adopts a more nuanced approach, setting different lower bounds for different life stages (Nordic Council of Ministers, 2023; Retterstøl & Rosqvist, 2024):

  • Adults (≥18 years): Lower bound of the reference intake range = 20 E% (same as EFSA).
  • Children 12–23 months: Lower bound = 30 E% (range 30–40 E%).
  • Infants 6–11 months: Lower bound = 30 E% (range 30–45 E%).
  • Children 2–17 years: Gradually decreasing from approximately 30 E% in early childhood towards 20–25 E% in late adolescence, in line with declining energy requirements per kg body weight.

The higher lower bounds for young children reflect their rapid growth, high brain lipid accumulation (particularly docosahexaenoic acid, DHA), and the higher fat content of breast milk and traditional complementary foods. The NNR2023 committee explicitly notes that fat intakes below 25 E% in children aged 6–23 months “have been associated with low vitamin levels in some young children” (Nordic Council of Ministers, 2023, Section “Science advice for a healthy and environment‑friendly diet”).

For older children and adults, the 20 E% lower bound is considered safe and compatible with nutritional adequacy provided that the diet includes sufficient sources of essential fatty acids (e.g., vegetable oils, nuts, seeds, fatty fish) and that energy intake meets requirements.

WHO (2023): Lower Bound as a Qualification

The WHO 2023 guideline on total fat intake does not explicitly set a lower bound in the same way as EFSA or NNR. Instead, it qualifies the conditional recommendation to limit fat to ≤30 E% by stating that:

To ensure an adequate intake of energy and essential fatty acids, and to facilitate the absorption of lipid‑soluble vitamins, total fat intake in most adults should be at least 15–20% of total energy intake (WHO, 2023, Remarks for recommendation 1).

The WHO acknowledges that in populations where undernutrition is prevalent and total fat intake may already be low, maintaining or even increasing fat intake (in line with guidance on fat quality) may be necessary to achieve adequate energy intake. This cautious approach reflects the global scope of the guideline, which must be applicable in both low‑income and high‑income settings.

3.3. Risks and Physiological Consequences of Very Low‑Fat Diets

While very low‑fat diets (e.g., < 15 E%) are rarely consumed by free‑living populations in industrialised countries, their effects have been studied in controlled settings and in specific clinical contexts. The following physiological changes have been observed, none of which are recommended for general populations without medical supervision:

  • Reduced HDL cholesterol and increased triglycerides: Meta‑analyses of controlled feeding studies show that when total fat falls below approximately 20–25 E% and is replaced by carbohydrates (especially refined carbohydrates), HDL cholesterol decreases and fasting triglycerides increase (EFSA, 2010, Section 5.2.1; Mensink et al., 2003, as cited in Retterstøl & Rosqvist, 2024).
  • Impaired fat‑soluble vitamin status: As noted earlier, very low‑fat meals reduce the absorption of vitamin A, vitamin E, and β‑carotene. Long‑term very low‑fat diets may lead to suboptimal plasma concentrations of these vitamins, particularly in individuals with already low intakes of fruits and vegetables (EFSA, 2010).
  • Essential fatty acid deficiency (extremely rare): In the absence of medical conditions (e.g., fat malabsorption, prolonged total parenteral nutrition without lipid emulsions), essential fatty acid deficiency is virtually unknown in the general population. However, intakes of linoleic acid below 1–2 E% have produced deficiency signs in infants (EFSA, 2010, Section 5.1.2.1).

It is important to emphasise that these risks are associated with habitual very low fat intakes over extended periods. Short‑term very low‑fat diets (e.g., for weight loss under medical supervision) may not produce the same adverse effects, but such interventions are outside the scope of this article.

3.4. The Lower Bound in the Context of Energy Balance and Physical Activity

The lower threshold of 20 E% is a relative value. A physically active adult with high energy expenditure (e.g., PAL 1.8, energy requirement ≈12.5 MJ/day or 3000 kcal/day) would consume approximately 67 g of fat per day at 20 E%, which is more than double the absolute fat intake of a sedentary adult with low energy requirement (e.g., PAL 1.4, ≈1500 kcal/day, 33 g fat/day at 20 E%). Thus, the absolute amount of fat needed to meet essential fatty acid and vitamin absorption requirements is better met in active individuals even at the same relative percentage.

The NNR2023 explicitly recognises this interplay: for planning purposes, a total fat intake of 25–40 E% is recommended, but within that range, active individuals can and should consume fat at the higher end, while less active individuals should aim for the lower end (Nordic Council of Ministers, 2023; Cloetens & Ellegård, 2023).

3.5. Summary: The Lower Bound as a Safeguard Against Inadequacy

In summary, the lower bound of total fat intake (approximately 20 E% for adults, 30 E% for infants and young children) serves as a safeguard against three forms of nutritional inadequacy:

  • Insufficient intake of essential n‑6 and n‑3 polyunsaturated fatty acids.
  • Reduced absorption of fat‑soluble vitamins and carotenoids.
  • Inadequate energy density for young children with high growth demands.

Unlike the upper bound, which is influenced by lifestyle factors (physical activity, obesity risk), the lower bound is more strictly rooted in fundamental biochemical and physiological requirements. It is therefore less variable across guidelines and is consistently set at 15–20 E% for adults and higher for children under two years of age.

The next section will explore how these quantitative norms are distributed across different age groups, from infancy to older adulthood, and how reference values for total fat are integrated with recommendations for individual fatty acid classes.

4. Distribution of Fat Intake Across Age Groups

Dietary fat requirements are not uniform across the lifespan. The proportion of energy derived from fat is highest in infancy, when human milk provides approximately 50–55 E% fat, and gradually declines through childhood and adolescence to reach adult levels by late adolescence. This age‑dependent decline reflects changes in growth velocity, brain development, and energy requirements per kilogram of body weight. This section presents the quantitative recommendations for total fat intake for each life stage, as established by EFSA (2010) and the Nordic Nutrition Recommendations 2023 (NNR2023), with additional context from the WHO (2023) guideline where applicable.

4.1. Infants (0–12 months)

0–6 months: exclusive breastfeeding as the reference

For the first six months of life, exclusive breastfeeding is recommended as the sole source of nutrition (Nordic Council of Ministers, 2023; EFSA, 2010). Human milk typically provides 50–55% of total energy from fat, with a fatty acid composition that includes approximately 40–45% saturated fatty acids, 40–45% monounsaturated fatty acids, and 13–16% polyunsaturated fatty acids, including preformed long‑chain PUFA such as arachidonic acid (ARA) and docosahexaenoic acid (DHA) (EFSA, 2010, Section 5.1.2). No separate dietary reference value for total fat is set for this age group; the observed intake from breast milk serves as the reference (Adequate Intake, AI) (Nordic Council of Ministers, 2023).

For formula‑fed infants, EU regulations require that infant formula provides 40–55 E% from fat (as cited in Retterstøl & Rosqvist, 2024), ensuring a fat intake comparable to that of breastfed infants.

6–11 months: introduction of complementary feeding

From 6 months onwards, complementary foods are introduced while breastfeeding continues. The fat intake gradually decreases from the very high levels of exclusive breastfeeding to approximately 30–45 E% (NNR2023) or 30–40 E% (EFSA, 2010). The NNR2023 specifies a range of 30–45 E% for infants aged 6–11 months (Nordic Council of Ministers, 2023, Section “Science advice for a healthy and environment‑friendly diet”).

The higher lower bound (30 E%) compared to adults (20 E%) reflects several factors:

  • High energy requirements per kg body weight: Infants have a small stomach capacity and high growth demands. Fat provides a concentrated energy source, helping to meet energy needs without excessive food volume.
  • Brain development: The brain continues to accumulate DHA and ARA during the second half of the first year, requiring adequate dietary fat (EFSA, 2010, Section 5.11).
  • Fat‑soluble vitamin absorption: Fat intakes below 25 E% in this age group have been associated with low plasma levels of vitamin A and other fat‑soluble vitamins in some studies (EFSA, 2010, Section 5.1.1.4).

The NNR2023 committee emphasises that fat intake should not fall below 25 E% in infants and young children without medical supervision (Nordic Council of Ministers, 2023).

4.2. Children 1–3 years

During the second and third years of life, the recommended total fat intake is 30–40 E% according to NNR2023 (Nordic Council of Ministers, 2023), while EFSA (2010) does not provide a separate range for this age group but notes that fat intakes can gradually approach adult levels by the end of the third year. The STRIP trial (Special Turku Coronary Risk Factor Intervention Project) demonstrated that a moderately restricted fat intake of 25–30 E% from 7 months to 18 years of age was not associated with compromised growth or neurological development, suggesting that intakes as low as 25 E% can be safe if overall diet quality is adequate (Niinikoski et al., 1996, as cited in EFSA, 2010, Section 5.1.1.4).

Nevertheless, the NNR2023 maintains a higher lower bound (30 E%) for children 1–3 years to provide a margin of safety for energy and essential fatty acid adequacy (Nordic Council of Ministers, 2023). For planning purposes, a target of approximately 35 E% is often used for this age group.

4.3. Children 4–10 years

From age 4 to 10 years, the reference intake range for total fat progressively narrows towards the adult range. The NNR2023 does not specify a separate range for this age group but expects a gradual decline from the 30–40 E% range of early childhood towards the 25–40 E% range for older children and adolescents (Nordic Council of Ministers, 2023, Appendix 6). EFSA (2010) notes that by age 4–6 years, total fat intakes as low as 25–30 E% are compatible with normal growth, provided that energy requirements are met and the diet includes sufficient essential fatty acids.

Observational data from European surveys show that mean total fat intakes in children aged 7–9 years range from 31 to 36 E%, with 5th percentile values around 23–27 E% and 95th percentile values around 40–46 E% (EFSA, 2010, Annex 1b). These intakes are generally within or slightly above the recommended ranges.

4.4. Adolescents (11–17 years)

For adolescents, both EFSA (2010) and NNR2023 apply the adult reference intake range, but with some age‑specific considerations. The NNR2023 sets the range at 25–40 E% for adolescents aged 11–17 years (Nordic Council of Ministers, 2023, Appendix 6). The lower bound of 25 E% is used for planning purposes, but the physiological lower bound of 20 E% (as for adults) is considered acceptable provided that diet quality is high (Retterstøl & Rosqvist, 2024).

Table. Reference values for total fat intake by age group according to NNR2023.

Age group Recommended intake range (E%) Notes
6–11 months 30–45 Higher lower bound for rapid growth and brain development
12–23 months 30–40 Gradual decline from infant levels
2–3 years 30–40 (target ~35) Adapted from 1–3 year range
4–10 years 25–40 (progressive decline) Approaches adult range
11–17 years 25–40 Adult range applies
Adults (≥18 years) 25–40 (NNR) / 20–35 (EFSA) Lower bound 20–25 E% depending on activity
Elderly (>70 years) 25–40 (same as adults) No reduction; maintain energy density

4.5. Adults (18–70 years)

For adults, two authoritative ranges are in use:

  • EFSA (2010): 20–35 E% (reference intake range)
  • NNR2023: 25–40 E% (reference intake range, with a target of 25–35 E% for less active individuals)

The differences reflect the different contexts and primary endpoints discussed in Section 2. For sedentary adults with healthy body weight, a total fat intake of 20–30 E% is generally appropriate; for active adults, intakes up to 35–40 E% are compatible with good health (Nordic Council of Ministers, 2023; WHO, 2023).

4.6. Elderly (>70 years)

For adults aged 70 years and older, the NNR2023 does not lower the total fat recommendation. The range remains 25–40 E% (Nordic Council of Ministers, 2023, Appendix 4). This is an important point because in older adults, preventing unintended weight loss and maintaining energy balance often becomes more critical than limiting fat intake. Energy requirements per kg body weight decrease with age due to reduced physical activity and loss of lean mass, but fat as a percentage of total energy can remain within the same range. The absolute fat intake (in grams) will be lower if total energy intake is lower.

EFSA (2010) did not set separate values for the elderly, assuming that the adult reference intake range (20–35 E%) also applies to those over 65 years, provided that the diet is nutritionally adequate.

4.7. Special considerations: pregnancy and lactation

Pregnancy and lactation increase energy requirements but do not alter the relative proportion of fat in the diet. The NNR2023 and EFSA both recommend that pregnant and lactating women maintain the same total fat range as non‑pregnant adults (20–35 E% or 25–40 E%), with an emphasis on adequate intake of essential fatty acids and DHA (Nordic Council of Ministers, 2023; EFSA, 2010). However, the absolute intake of fat (in grams) increases in parallel with increased energy requirements. For example, in the third trimester, total energy requirement increases by approximately 2.3 MJ/day (550 kcal/day) compared to non‑pregnant state, leading to an additional 15–25 g of fat per day at 30 E% (Nordic Council of Ministers, 2023, Appendix 4).

4.8. Summary of Age‑Dependent Fat Recommendations

In summary, the proportion of energy from fat is highest during infancy (≈50 E% from breast milk, 30–45 E% during complementary feeding) and gradually declines to adult levels by late adolescence. The adult range of 20–35 E% (EFSA) or 25–40 E% (NNR2023) is maintained throughout adulthood and into old age, with the lower bound adjusted for physical activity and body weight status. For children under two years, a higher lower bound (30 E%) is recommended to support rapid growth and neurological development. These quantitative norms provide a framework for dietary planning, but individual needs may vary based on genetics, physical activity, and overall diet quality.

The next section will discuss how these quantitative recommendations for total fat integrate with the distribution of fatty acid classes (saturated, monounsaturated, polyunsaturated, and trans fats) within the total energy budget.

5. Recommended Ranges for Fatty Acid Classes: The Overall Energy Structure

Diagram: foods to consume more (fruits, nuts, vegetables, fish) and less (red meat, processed meat, sugar, salt)

Evidence-based dietary priorities for cardiometabolic health

The placement of each food/factor is based on its net effects on cardiometabolic health and the strength of evidence. Mozaffarian (2016), figure 3. CC BY 4.0

Quantitative recommendations for total fat provide only part of the picture. Within the total fat allowance, different classes of fatty acids – saturated (SFA), monounsaturated (MUFA), polyunsaturated (PUFA), and trans (TFA) – have distinct metabolic effects and, consequently, different dietary reference values. Importantly, these recommendations are interdependent: because the sum of all fatty acid classes must equal total fat intake (expressed as a percentage of total energy), a change in the recommended intake of one class necessarily requires adjustment of another class or of total fat itself.

Forest plot: relative risks for SFA, MUFA, PUFA across outcomes

Summary of associations of SFA, MUFA, and PUFA intake with mortality and morbidity

Higher PUFA intake is associated with lower all-cause and cardiovascular mortality. Ma et al. (2024), figure 3. CC BY 4.0

This section outlines the recommended ranges for each fatty acid class as established by the Nordic Nutrition Recommendations 2023 (NNR2023) and EFSA (2010), and shows how they fit within the total fat energy budget. Detailed mechanistic discussions of individual fatty acids are beyond the scope of this article; the focus here is on the quantitative structure of dietary fat recommendations.

5.1. The Interdependence of Fatty Acid Recommendations

Total fat intake (E%) can be expressed as the sum of its components:

Total fat (E%) = SFA (E%) + MUFA (E%) + PUFA (E%) + TFA (E%) + other fatty acids (negligible)

Since total fat is limited to a range (e.g., 25–40 E% in NNR2023), the sum of the individual fatty acid classes cannot exceed this total. This mathematical constraint has practical implications: if a diet is very high in one class (e.g., SFA), there is less room for other classes (e.g., PUFA) within the same total fat budget. Conversely, to meet the recommended intake for PUFA (which has a lower bound), total fat cannot be too low, and SFA must be restricted to free up energy percentage for unsaturated fats.

5.2. Saturated Fatty Acids (SFA): “As Low as Possible”

All authoritative guidelines agree that saturated fatty acids are not essential nutrients – the body can synthesise them – and that high intakes are associated with adverse effects on blood lipid profiles (EFSA, 2010; Nordic Council of Ministers, 2023; WHO, 2023). Consequently, no Average Requirement (AR), Recommended Intake (RI), or Adequate Intake (AI) is set for SFA.

The quantitative recommendation for SFA is expressed as an upper limit:

  • EFSA (2010): SFA intake should be “as low as possible within the context of a nutritionally adequate diet”. No specific E% value is set, but the Panel notes that in many European populations, average SFA intakes exceed 10 E%, and efforts to lower them are warranted.
  • NNR2023: SFA intake should be limited to less than 10 E% (Nordic Council of Ministers, 2023; Retterstøl & Rosqvist, 2024).
  • WHO (2023): Strong recommendation to limit SFA intake to ≤10 E% (for both adults and children, with replacement by PUFA).

The 10 E% upper limit is derived from the observation that reducing SFA from higher levels to below 10 E% (with isoenergetic replacement by PUFA or MUFA) significantly lowers LDL cholesterol, a causal risk factor for atherosclerotic cardiovascular disease (Sacks et al., 2017; Hooper et al., 2020). However, because the relationship between SFA intake and LDL cholesterol is continuous (no threshold), any further reduction below 10 E% would theoretically confer additional benefit, but practical limitations of dietary patterns make levels much below 7–8 E% difficult to achieve in mixed diets without compromising nutritional adequacy (EFSA, 2010).

5.3. Trans Fatty Acids (TFA): A Separate Upper Limit

Trans fatty acids (both industrial and ruminant-derived) have adverse effects on blood lipids and are associated with increased cardiovascular risk (EFSA, 2010; de Souza et al., 2015, as cited in Retterstøl & Rosqvist, 2024). Like SFA, TFA are not essential.

  • EFSA (2010): TFA intake should be “as low as possible within the context of a nutritionally adequate diet”. No numeric target is given, but intakes below 1 E% are considered achievable.
  • NNR2023: Recommends that TFA intake be kept “as low as possible”, with the practical goal of less than 1 E% (Nordic Council of Ministers, 2023). In Nordic countries, average TFA intakes have fallen to 0.5–0.6 E% due to product reformulation.
  • WHO (2023): Strong recommendation to limit TFA intake to ≤1 E% (replacing with PUFA).

Because TFA contribute to total fat but have no nutritional benefit, they are effectively an “anti‑nutrient”. In quantitative terms, the TFA recommendation subtracts from the total fat allowance that could otherwise be used for beneficial unsaturated fats.

5.4. Polyunsaturated Fatty Acids (PUFA): Lower Bounds as Adequate Intakes

In contrast to SFA and TFA, polyunsaturated fatty acids include the two essential fatty acids: linoleic acid (LA, n‑6) and α‑linolenic acid (ALA, n‑3). Therefore, lower intake thresholds are set to prevent deficiency.

Total PUFA

  • NNR2023: Recommends that PUFA provide 5–10 E% of total energy (Nordic Council of Ministers, 2023). At least 1 E% should come from n‑3 fatty acids (including ALA and long‑chain n‑3 PUFA).
  • EFSA (2010): Does not set a total PUFA reference value, but provides AIs for individual essential fatty acids (see below).

Linoleic acid (LA, n‑6)

  • EFSA (2010): Adequate Intake (AI) of 4 E% for adults. This is based on the lowest estimated mean intakes in European populations where overt LA deficiency symptoms are absent. No UL is set, as no consistent evidence of harm from high LA intakes has been demonstrated.
  • NNR2023: Adopts the same AI of 4 E% for LA (Nordic Council of Ministers, 2023; Retterstøl & Rosqvist, 2024).

α‑Linolenic acid (ALA, n‑3)

  • EFSA (2010): AI of 0.5 E% for adults, based again on observed intakes in healthy European populations.
  • NNR2023: AI of 0.5 E% for ALA. For pregnant and lactating women, the n‑3 PUFA recommendation is increased to 1 E%, of which at least 200 mg/day should be preformed DHA (Nordic Council of Ministers, 2023).

Long‑chain n‑3 PUFA (EPA + DHA)

  • EFSA (2010): AI of 250 mg/day for eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) for adults, based on cardiovascular health considerations.
  • NNR2023: Adopts the same AI of 250 mg/day for EPA + DHA. For infants (6–24 months), an AI of 100 mg/day DHA is set to support visual and neurological development (Nordic Council of Ministers, 2023).

5.5. Monounsaturated Fatty Acids (MUFA): Calculated by Difference

Monounsaturated fatty acids (primarily oleic acid, 18:1n‑9) are not essential because the body can synthesise them from saturated fatty acids. No lower or upper reference values are set for MUFA independently. Instead, MUFA intake is calculated by difference after accounting for SFA, PUFA, and TFA:

MUFA (E%) = Total fat (E%) − SFA (E%) − PUFA (E%) − TFA (E%)

This approach is taken by both EFSA (2010) and NNR2023 (Nordic Council of Ministers, 2023). For planning purposes, if total fat is set at 30–35 E%, SFA < 10 E%, PUFA 5–10 E%, and TFA < 1 E%, then MUFA will naturally fall into the range of approximately 10–20 E%. This aligns with the traditional Mediterranean dietary pattern where olive oil (rich in MUFA) is a major fat source.

5.6. Integrating the Components: A Quantitative Example

To illustrate how these recommendations fit together, consider a typical adult aiming for a total fat intake of 30 E% (mid‑point of the EFSA range). Using NNR2023 targets:

  • Total fat: 30 E%
  • SFA: < 10 E% (e.g., 9 E%)
  • TFA: < 1 E% (e.g., 0.5 E%)
  • PUFA: 5–10 E% (e.g., 7 E%, of which LA 4 E%, ALA 0.5 E%, the remainder from other PUFA)
  • MUFA: Calculated by difference: 30 − 9 − 0.5 − 7 = 13.5 E%

This 13.5 E% MUFA falls within the desirable range of 10–20 E% and allows for a diet rich in olive oil, canola oil, or nuts. If total fat is higher (e.g., 35 E% for an active individual), MUFA would increase proportionally, assuming SFA and PUFA are kept within their recommended ranges.

5.7. Summary: The Energy Budget Approach

The quantitative recommendations for fatty acid classes can be summarised as follows:

  • SFA: Upper limit < 10 E% (as low as possible within a nutritionally adequate diet).
  • TFA: Upper limit < 1 E% (as low as possible).
  • PUFA (total): 5–10 E% (including at least 1 E% from n‑3).
  • LA (n‑6): AI 4 E%
  • ALA (n‑3): AI 0.5 E%
  • EPA + DHA: AI 250 mg/day (adults)
  • MUFA: No direct target; determined by difference.
  • Total fat: 20–35 E% (EFSA) or 25–40 E% (NNR2023), serving as the envelope that contains all fatty acid classes.

This structure ensures that when total fat is within the recommended range and SFA and TFA are limited, the diet will automatically contain adequate amounts of essential PUFA and a favourable proportion of MUFA. The energy budget approach also simplifies public health messaging: rather than trying to achieve multiple independent fatty acid targets, consumers can focus on reducing SFA and TFA, increasing sources of PUFA (vegetable oils, nuts, seeds, fatty fish), and adjusting total fat according to energy needs and physical activity level.

The final section will conclude the article by summarising the key quantitative norms and reiterating their educational and practical relevance.

6. How the Norms Were Established: A Brief Overview of Methodology

The quantitative norms for total fat and fatty acid classes described in the preceding sections did not emerge from a single study or a simple calculation. Rather, they are the result of decades of methodologically diverse research, including early balance studies, large prospective cohort studies, randomised controlled trials (RCTs), and systematic reviews with meta‑analyses. Understanding how these norms were derived – and why they sometimes differ between authorities – is essential for interpreting and applying them correctly.

This section provides a concise, educational overview of the methodological approaches used to set dietary reference values for fats, without delving into clinical controversies or therapeutic applications.

6.1. From Balance Studies to Observational Epidemiology

Early balance and depletion‑repletion studies

For essential nutrients (e.g., iron, calcium, some vitamins), classical balance studies measure intake against excretion to determine the intake level required to maintain zero net loss. For essential fatty acids (linoleic acid, LA; α‑linolenic acid, ALA), depletion‑repletion studies in humans and animals established the minimum intake needed to prevent deficiency signs (e.g., dry scaly skin, elevated triene:tetraene ratio). These studies showed that LA intakes below 0.5–1 E% produce biochemical and clinical deficiency, while intakes above 2–3 E% are sufficient to maintain normal status (EFSA, 2010, Section 5.1.2.1).

For total fat, however, balance studies are not informative because the body can synthesise fatty acids from carbohydrates and store them in adipose tissue. No classical “requirement” for total fat exists beyond the sum of requirements for essential fatty acids and the facilitation of fat‑soluble vitamin absorption. Consequently, lower bounds for total fat have been derived from observed intakes in healthy populations rather than from depletion studies.

Use of observed intakes to set Adequate Intakes (AIs)

When evidence is insufficient to derive an Average Requirement (AR), authorities such as EFSA and the Nordic Council of Ministers set an Adequate Intake (AI) based on the observed mean intake of a healthy, apparently well‑nourished population (Christensen et al., 2020). For LA and ALA, the AIs of 4 E% and 0.5 E%, respectively, were set using this approach: they represent the lowest estimated mean intakes in European populations where no overt deficiency symptoms are present (EFSA, 2010). For total fat in adults, the lower bound of 20 E% was similarly informed by the lowest observed intakes in European surveys (EFSA, 2010; Nordic Council of Ministers, 2023).

6.2. The Role of Systematic Reviews and Meta‑Analyses

Modern dietary reference values rely heavily on systematic reviews (SRs) and meta‑analyses that synthesise all available high‑quality evidence on a specific exposure–outcome pair. The NNR2023 project, for example, used approximately 100 qualified systematic reviews (qSRs) as the main fundament for setting DRVs (Nordic Council of Ministers, 2023). These reviews were commissioned or conducted by authoritative bodies such as WHO, EFSA, the US Dietary Guidelines Advisory Committee (DGAC), and the Cochrane Collaboration.

For total fat and fatty acids, key systematic reviews included:

  • Hooper et al. (2020): A Cochrane review of RCTs assessing effects of total fat reduction on body fatness in adults. This review provided the primary evidence base for the WHO 2023 conditional recommendation (WHO, 2023).
  • Hooper et al. (2020) on saturated fat: A Cochrane review of 15 RCTs (59,000 participants) evaluating the effect of reducing SFA on cardiovascular events. This review confirmed that replacing SFA with PUFA reduces combined cardiovascular events (Hooper et al., 2020, as cited in Retterstøl & Rosqvist, 2024).
  • Mensink et al. (2003): A meta‑analysis of 60 controlled trials quantifying the effects of different fatty acids on blood lipids (total cholesterol, LDL, HDL, triglycerides). This work underpins the quantitative relationships used to derive SFA and PUFA recommendations (Mensink et al., 2003, as cited in EFSA, 2010; Retterstøl & Rosqvist, 2024).
  • de Souza et al. (2015): A large systematic review of observational studies on SFA, TFA, and cardiovascular disease, cited in multiple guidelines (Retterstøl & Rosqvist, 2024).

Systematic reviews are graded for quality using tools such as AMSTAR 2, and only those meeting predefined criteria (e.g., clear search strategy, risk of bias assessment, no industry‑sponsored conflicts) are used as qualified SRs in the NNR2023 project (Nordic Council of Ministers, 2023; Arnesen et al., 2020).

6.3. Evidence from Randomised Controlled Trials (RCTs)

RCTs provide the highest level of evidence for causal inference. For dietary fat recommendations, three types of RCTs have been particularly influential:

1. Controlled feeding trials (metabolic ward studies): Participants receive precisely formulated diets differing only in fat composition. These trials establish dose–response relationships between specific fatty acids and surrogate endpoints (e.g., LDL cholesterol). The Mensink (2003) meta‑analysis is the classic example.

2. Long‑term dietary intervention trials: Free‑living participants are randomised to different dietary patterns (e.g., low‑fat vs. Mediterranean diet). Outcomes include clinical events (myocardial infarction, stroke, death) or hard surrogate markers. Examples include the Women’s Health Initiative (WHI), the PREDIMED trial, and the Oslo Diet‑Heart Study (Sacks et al., 2017; Retterstøl & Rosqvist, 2024). These trials demonstrated that replacing SFA with PUFA reduces cardiovascular events, whereas reducing total fat without attention to fat quality does not.

3. Trials with body weight as the primary outcome: The WHO 2023 guideline on total fat relied on a systematic review of RCTs in which weight loss was not an explicit goal. These trials showed that reducing total fat leads to modest but significant reductions in body weight, BMI, and waist circumference (high certainty evidence). The dose–response relationship informed the selection of the 30 E% upper bound (WHO, 2023).

It is important to note that dietary RCTs face unique challenges: blinding is difficult, long‑term adherence is variable, and the effect sizes for clinical endpoints are often modest. Nevertheless, when multiple well‑designed RCTs converge with prospective cohort studies, the evidence is considered robust.

6.4. The Distinction Between “Strong” and “Conditional” Recommendations (WHO GRADE)

The World Health Organization uses the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework to rate the certainty of evidence and the strength of recommendations (WHO, 2023). Two types of recommendations are issued:

  • Strong recommendation: The guideline panel is confident that the desirable consequences of implementing the recommendation outweigh the undesirable consequences. Such recommendations can be adopted as policy in most situations.
  • Conditional recommendation: The panel is less certain that the desirable effects outweigh the undesirable effects, or the net benefit is very small. Substantive discussion may be required before adoption as policy.

In the 2023 total fat guideline, the recommendation to limit total fat to 30 E% or less is conditional. The reasons include:

  • Some individuals who reduce fat intake might replace the energy with undesirable foods (e.g., free sugars), reducing net benefit.
  • The evidence applies primarily to prevention of unhealthy weight gain, not to management of existing obesity or to all populations globally.
  • There is variability in how populations respond to fat reduction depending on baseline dietary patterns and physical activity levels.

In contrast, the recommendations to limit SFA to ≤10 E% and TFA to ≤1 E% are strong, based on high‑certainty evidence for cardiovascular benefits (WHO, 2023).

6.5. Integration of Evidence: How EFSA and NNR Arrive at Ranges

Both EFSA and the NNR2023 committee use a structured, multi‑step process to derive DRVs (Christensen et al., 2020; EFSA, 2010):

1. Identify the indicator: For total fat, indicators include energy balance, body fatness, and fat‑soluble vitamin status. For SFA, the key indicator is LDL cholesterol.

2. Review the evidence: Systematic reviews of RCTs and prospective cohort studies are evaluated for risk of bias and consistency.

3. Assess dose–response: Where possible, a dose–response curve is established. For SFA, the relationship with LDL cholesterol is continuous (no threshold). For total fat, a dose–response relationship with body weight was observed in the Hooper et al. (2020) meta‑analysis.

4. Consider feasibility and practical ranges: The final reference intake range is not purely mathematical; it also considers current intake levels, achievable dietary patterns, and cultural acceptability. For example, the NNR2023 upper bound of 40 E% is higher than EFSA’s 35 E% partly because Nordic populations have higher habitual physical activity and traditionally higher fat intakes (Nordic Council of Ministers, 2023).

5. Apply uncertainty and scaling: When an AR cannot be set (as for total fat), the lower bound is based on observed intakes in healthy populations (AI approach). For children and pregnant/lactating women, values are extrapolated from adult data using physiological scaling (allometric or isometric) and growth factors (Nordic Council of Ministers, 2023, Appendix 5).

6.6. Limitations and Ongoing Methodological Challenges

Despite rigorous methods, setting quantitative norms for dietary fat involves inherent uncertainties:

  • Measurement error in dietary assessment: Food frequency questionnaires and recalls are imprecise, leading to attenuation of true associations in observational studies.
  • Residual confounding: In cohort studies, it is difficult to fully separate the effects of total fat from those of other dietary and lifestyle factors.
  • Heterogeneity of fat sources: The metabolic effects of SFA may differ depending on the food matrix (e.g., dairy vs. meat). Current guidelines do not fully capture these nuances, although the NNR2023 discusses them (Retterstøl & Rosqvist, 2024).
  • Lack of RCTs for some endpoints: Long‑term RCTs with clinical endpoints are expensive and difficult to conduct for total fat. Much of the evidence for the lower bound still relies on observational data and mechanistic reasoning.

Future methodological developments may include greater use of individual participant data (IPD) meta‑analyses, substitution modelling (replacing one nutrient with another), and integration of environmental sustainability considerations (Nordic Council of Ministers, 2023; Lovegrove, 2025).

6.7. Summary

The quantitative norms for total fat and fatty acids are based on a hierarchy of evidence: balance studies and observed intakes for essential fatty acids; controlled feeding trials and meta‑analyses for lipid biomarkers; long‑term RCTs for cardiovascular events and body weight; and prospective cohort studies for dose–response and generalisability. Systematic reviews synthesise this evidence, and expert panels apply GRADE or similar frameworks to formulate recommendations. Differences between guidelines (e.g., 35% vs. 40% upper bound) reflect different primary endpoints, population characteristics, and practical considerations, not contradictions in the underlying science.

The final section will summarise the key quantitative norms for lipid intake and discuss their practical and educational relevance.

7. Comparison of Approaches Across Major Guidelines: EFSA, NNR, and WHO

Bar chart: changes in LDL cholesterol (mmol/L) in 109 males, ranging from –38% to +19%

Individual changes in serum LDL cholesterol in response to replacing saturated with unsaturated fatty acids

Although mean LDL cholesterol decreased by 0.5–1 mmol/L, individual responses varied from –38% to +19%, explaining why reference values are set as ranges rather than single numbers. Lovegrove (2025), figure 4. CC BY 4.0

Different authoritative bodies have issued quantitative recommendations for total fat intake that, while broadly similar, differ in detail. Understanding the reasons for these differences is important for nutrition scientists, policy makers, and educators, as it prevents the mistaken belief that one guideline is “right” and the others are “wrong”. Instead, the differences reflect distinct primary endpoints, target populations, regional dietary patterns, and the specific evidence base prioritised by each expert panel.

This section compares the approaches of three major guidelines: the European Food Safety Authority (EFSA, 2010), the Nordic Nutrition Recommendations 2023 (NNR2023), and the World Health Organization (WHO, 2023). A summary table is provided, followed by a discussion of the rationale for each recommendation.

7.1. Summary of Key Quantitative Differences

Table. Comparison of total fat recommendations from EFSA, NNR2023, and WHO.

Parameter EFSA (2010) NNR2023 WHO (2023)
Target population General European population (adults 18+) Nordic and Baltic populations (adults 18+) Global adult population (≥20 years)
Recommended range (E%) 20–35% 25–40% (target 25–35% for less active) Conditional: ≤30%
Lower bound rationale Lowest observed intake in European populations without deficiency Age‑dependent (30% for children &lt; 2 years, 20–25% for adults); ensures essential fatty acids and energy density Not explicitly set, but stated that adults should have at least 15–20% for adequacy
Upper bound rationale Prevention of excess energy intake and unfavourable lipid profile Flexibility for active populations; fat quality emphasised over quantity Primary prevention of unhealthy weight gain (body fatness)
Primary endpoint(s) Nutritional adequacy, blood lipids, energy balance Blood lipids, body weight, environmental sustainability (the latter not quantified) Body weight, BMI, waist circumference, percentage body fat
Strength of recommendation Reference intake range (scientific opinion) Reference intake range (consensus‑based) Conditional recommendation (GRADE)
Consideration of physical activity Implicit (energy % adjusts for activity) Explicit (PAL values used; higher bound for active individuals) Acknowledged as effect modifier but not incorporated into the numeric target

7.2. European Food Safety Authority (EFSA, 2010)

The EFSA opinion was developed in response to a request from the European Commission to update the 1993 Scientific Committee for Food (SCF) report. The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) conducted a comprehensive review of the evidence on fats, fatty acids, and cholesterol, with a focus on nutritional adequacy, blood lipids, and prevention of chronic diseases (EFSA, 2010).

Key features of the EFSA approach:

  • Lower bound (20 E%): Based on the lowest observed total fat intakes in European population surveys that were not associated with overt signs of essential fatty acid deficiency or vitamin insufficiency. The Panel noted that intakes below 20 E% increase the risk of inadequate intake of linoleic acid, α‑linolenic acid, and fat‑soluble vitamins.
  • Upper bound (35 E%): Selected because total fat intakes above 35 E% are associated with higher energy intake and, in sedentary populations, greater body fatness. The Panel also considered that at intakes above 35 E%, it becomes more difficult to keep SFA below 10 E% and to maintain a favourable ratio of unsaturated to saturated fats. However, they explicitly stated that intakes above 35 E% “may be compatible with both good health and normal body weight depending on dietary patterns and the level of physical activity” (EFSA, 2010, p. 51).
  • Primary endpoints: The EFSA opinion relied heavily on controlled feeding trial data for blood lipids (Mensink et al., 2003) and on observational data for energy balance and body weight. It did not conduct a de novo systematic review on total fat and body weight (this was done later by WHO).
  • No separate range for children: EFSA provides guidance for infants and children in the narrative but does not set numeric reference intake ranges for total fat for ages 1–18 years, noting that fat intakes observed in European children (generally 30–35 E%) appear adequate.

7.3. Nordic Nutrition Recommendations 2023 (NNR2023)

The NNR2023 is the sixth edition of the Nordic Nutrition Recommendations, jointly produced by the five Nordic countries (Denmark, Finland, Iceland, Norway, Sweden) with participation of the Baltic states as observers. The NNR2023 is unique in that it explicitly integrates environmental sustainability considerations into the dietary guidelines, although the quantitative fat recommendations remain health‑based (Nordic Council of Ministers, 2023).

Key features of the NNR2023 approach:

Higher upper bound (40 E%): The range of 25–40 E% is wider and shifted upwards compared to EFSA. The main reasons are:

  • Nordic populations have higher habitual physical activity levels (average PAL 1.6–1.8) than many other European regions. Active individuals can consume a higher fat percentage without exceeding energy requirements.
  • The NNR2023 places strong emphasis on fat quality (replacing SFA with PUFA and MUFA) rather than strict limitation of total fat. Within a high‑quality diet rich in unsaturated vegetable oils, nuts, seeds, and fatty fish, total fat can reach 40 E% while maintaining a favourable fatty acid profile (Retterstøl & Rosqvist, 2024; Rosqvist & Niinistö, 2024).
  • The Nordic food culture traditionally includes moderate to high fat intakes (average 34–39 E% in recent surveys), and a target of 25–40 E% is realistic and acceptable (Lemming & Pitsi, 2022, as cited in Nordic Council of Ministers, 2023).

Age‑specific lower bounds: Unlike EFSA, the NNR2023 provides explicit lower bounds for infants and young children (30 E% for 6–23 months), acknowledging the higher energy requirements and brain development needs of this age group.

Integration with sustainability: Although environmental sustainability does not alter the numeric fat targets, the NNR2023 recommends shifting from animal fats to plant‑based unsaturated oils to reduce greenhouse gas emissions and land use (Nordic Council of Ministers, 2023).

Physical activity explicit: The NNR2023 provides reference energy requirements for different physical activity levels (PAL 1.4, 1.6, 1.8) and notes that less active individuals should aim for the lower end of the total fat range (25–30 E%).

7.4. World Health Organization (WHO, 2023)

The WHO guideline on total fat intake was developed as part of the organisation’s effort to update population nutrient intake goals for the prevention of noncommunicable diseases. Unlike the EFSA and NNR opinions, which consider multiple endpoints (lipids, vitamins, energy balance), the WHO guideline focused on a single primary endpoint: unhealthy weight gain (body fatness). This narrow focus explains the different numeric target (WHO, 2023).

Key features of the WHO approach:

1. Conditional recommendation for ≤30 E%: The WHO recommends that adults limit total fat intake to 30% of total energy or less for the prevention of unhealthy weight gain. This is a conditional recommendation, meaning that the panel was less certain that the desirable effects outweigh the undesirable consequences in all settings.

2. Evidence base: The recommendation is based on a systematic review of RCTs in which weight loss was not an explicit goal (Hooper et al., 2020). The review found high‑certainty evidence that reducing total fat leads to lower body weight, BMI, waist circumference, and percentage body fat. A dose–response relationship was observed, and subgroup analyses showed that achieving a total fat intake of ≤30 E% was associated with greater weight differences (WHO, 2023, Annex 6).

3. Why conditional? The guideline is conditional because:

  • Some individuals might replace fat with undesirable carbohydrates (free sugars), reducing net benefit.
  • The evidence applies primarily to prevention of weight gain, not to weight loss or management of established obesity.
  • There is variability in how populations respond to fat reduction depending on baseline diets and physical activity.

4. Lower bound qualification: The WHO does not set a numeric lower bound but notes that “to ensure an adequate intake of energy and essential fatty acids, and to facilitate the absorption of lipid‑soluble vitamins, total fat intake in most adults should be at least 15–20% of total energy intake” (WHO, 2023, Remarks for recommendation 1).

7.5. Why Do the Ranges Differ? A Reconciliation

The differences between the three guidelines are not contradictions but reflect different questions being asked:

  • EFSA asked: What range of total fat intake is compatible with nutritional adequacy and maintenance of favourable blood lipid profiles in European populations? The answer: 20–35 E%.
  • NNR2023 asked: What range of total fat intake is compatible with good health, high physical activity levels, and Nordic dietary patterns, while also allowing flexibility for active individuals? The answer: 25–40 E% (with the lower end for less active, upper end for more active).
  • WHO asked: What is the maximum total fat intake that should be recommended globally for the primary prevention of unhealthy weight gain, based on the best available RCT evidence? The answer: ≤30 E% (conditional).

These different questions lead to different numeric targets, but all three guidelines agree on several fundamental principles:

  1. SFA and TFA should be limited (< 10 E% for SFA, < 1 E% for TFA).
  2. PUFA intakes should meet Adequate Intakes (≥4 E% for LA, ≥0.5 E% for ALA, and 250 mg/day for EPA+DHA).
  3. The quality of dietary fat is more important than strict quantity – replacing SFA with PUFA is beneficial regardless of whether total fat is 30% or 40%.
  4. Physical activity level is a major determinant of how much total fat can be consumed without adverse effects on body weight.

7.6. Practical Implications for Dietary Planning

For a sedentary adult in an obesogenic environment, following the WHO recommendation of ≤30 E% is prudent. For an active, normal‑weight adult with a healthy dietary pattern, a total fat intake of 35–40 E% (as permitted by NNR2023) is entirely compatible with good health. The EFSA range of 20–35 E% provides a middle ground applicable to many European populations.

Crucially, none of the guidelines recommend increasing total fat intake in individuals who already consume less than the recommended lower bound, unless undernutrition is a concern. The lower bounds are safeguards, not targets to be achieved by adding fat to already adequate diets.

7.7. Future Harmonisation Efforts

There is growing recognition that harmonising approaches to deriving DRVs for macronutrients would be beneficial (Allen et al., 2020, as cited in Nordic Council of Ministers, 2023). The NNR2023 project explicitly aimed to align its life‑stage groups and methodologies with those of EFSA (Christensen et al., 2020). The WHO guidelines, while using GRADE, are designed for global applicability and therefore prioritise simplicity and strength of evidence for single endpoints.

Future updates may see greater convergence as more data become available from diverse populations, and as methodological frameworks for integrating multiple endpoints (e.g., both lipid profile and body weight) are refined.

The concluding section will summarise the key quantitative norms for lipid intake across all life stages and reiterate the core educational messages.

8. Conclusion

This article has provided a systematic, educational overview of the quantitative norms for dietary lipid intake, focusing on three core aspects: the energy contribution of total fat (expressed as a percentage of total energy, E%), the minimum threshold required to prevent nutritional inadequacy, and the distribution of these recommendations across different life stages. Drawing primarily on the dietary reference value frameworks of EFSA (2010), the Nordic Nutrition Recommendations 2023 (NNR2023), and the World Health Organization (WHO, 2023), several key conclusions emerge.

8.1. Total Fat: A Range, Not a Single Number

The most fundamental quantitative norm for total fat is that it should be expressed as a range of energy percentages, not as a single fixed value, because the body can adapt to a wide range of fat intakes and because individual energy requirements vary. The major guidelines propose the following ranges for healthy adults:

  • EFSA (2010): 20–35 E%
  • NNR2023: 25–40 E% (with a target of 25–35 E% for less active individuals)
  • WHO (2023): ≤30 E% (conditional recommendation for the prevention of unhealthy weight gain)

These differences are not contradictions but reflect different primary endpoints (blood lipids vs. body weight), target populations (European vs. Nordic vs. global), and the specific evidence base prioritised by each expert panel. All guidelines agree that the quality of dietary fat (i.e., the fatty acid profile) is at least as important as the quantity.

8.2. The Lower Bound: A Safeguard Against Inadequacy

The lower bound of total fat intake (approximately 20 E% for adults, 30 E% for infants and young children) serves as a safeguard against three forms of nutritional inadequacy:

1. Insufficient intake of the essential polyunsaturated fatty acids – linoleic acid (LA, n‑6) and α‑linolenic acid (ALA, n‑3). The Adequate Intakes for these are set at 4 E% and 0.5 E%, respectively.

2. Reduced absorption of fat‑soluble vitamins (A, D, E, K) and carotenoids, which require dietary fat for efficient micelle formation.

3. Inadequate energy density for young children with high growth demands and small stomach capacity.

Intakes below these lower bounds are not recommended for general populations without medical supervision, as they increase the risk of subclinical deficiencies.

8.3. The Upper Bound: Balancing Energy Intake and Physical Activity

The upper bound of total fat intake (35–40 E% depending on the guideline) is primarily justified by the need to prevent excess energy intake and subsequent unhealthy weight gain, particularly in sedentary populations. However, active individuals with higher energy requirements can consume a higher percentage of fat without adverse effects. The NNR2023 explicitly incorporates physical activity level (PAL) into its recommendations, advising that less active individuals aim for the lower end of the range (25–30 E%) and active individuals for the upper end (35–40 E%).

8.4. Age‑Dependent Norms

Quantitative fat recommendations are not uniform across the lifespan:

  • Infants (0–6 months): Exclusive breastfeeding provides approximately 50–55 E% from fat; this serves as the reference (Adequate Intake).
  • Infants (6–11 months) and young children (12–23 months): Higher lower bounds (30 E%) are recommended to support rapid growth, brain development, and energy density.
  • Children (2–17 years): Total fat intake gradually declines from approximately 30–40 E% in early childhood to 25–40 E% in adolescence, approaching adult ranges.
  • Adults (18–70 years) and elderly (>70 years): The adult range (20–35 E% or 25–40 E%) applies, with adjustment for physical activity. For the elderly, preventing unintended weight loss takes priority, so fat intake should not be unnecessarily restricted.
  • Pregnancy and lactation: The relative proportion of fat remains the same as for non‑pregnant adults, but absolute intake (in grams) increases in line with higher energy requirements.

8.5. Distribution of Fatty Acid Classes Within the Total Fat Budget

Quantitative recommendations for total fat are integrated with specific targets for fatty acid classes:

  • Saturated fatty acids (SFA): Upper limit < 10 E% (as low as possible within a nutritionally adequate diet). No lower bound is set because SFA are not essential.
  • Trans fatty acids (TFA): Upper limit < 1 E% (as low as possible). No nutritional benefit.
  • Polyunsaturated fatty acids (PUFA): 5–10 E% total, with Adequate Intakes for LA (4 E%) and ALA (0.5 E%), and an AI of 250 mg/day for EPA+DHA in adults.
  • Monounsaturated fatty acids (MUFA): No direct target; calculated by difference after accounting for SFA, PUFA, and TFA.

This energy budget approach ensures that when total fat is within the recommended range and SFA and TFA are limited, the diet will automatically contain adequate amounts of essential PUFA and a favourable proportion of MUFA.

8.6. Methodological Foundations

The quantitative norms for dietary fats are based on a hierarchy of evidence: early balance and depletion‑repletion studies for essential fatty acids; controlled feeding trials and meta‑analyses for lipid biomarkers (e.g., Mensink et al., 2003); long‑term randomised controlled trials for cardiovascular events (e.g., Hooper et al., 2020) and body weight (WHO, 2023); and prospective cohort studies for dose–response relationships and generalisability. Systematic reviews synthesise this evidence, and expert panels apply GRADE or similar frameworks to formulate recommendations. Differences between guidelines reflect different primary endpoints, population characteristics, and practical considerations, not fundamental disagreements in the underlying science.

8.7. Practical and Educational Relevance

For nutrition educators, policy makers, and informed consumers, the following key messages are most important:

  • There is no single “correct” percentage of energy from fat. The optimal intake depends on age, physical activity level, body weight status, and overall diet quality.
  • Lowering total fat without attention to fat quality is not beneficial. Replacing saturated and trans fats with unsaturated fats (from vegetable oils, nuts, seeds, and fatty fish) is more important than simply reducing the total amount of fat.
  • Very low‑fat diets (< 15–20 E%) carry risks of essential fatty acid deficiency, impaired fat‑soluble vitamin absorption, and, in children, inadequate energy intake.
  • Active individuals can tolerate and benefit from higher fat intakes (up to 35–40 E%) because their higher energy expenditure allows them to consume more grams of fat within the same E% range, and because unsaturated fats from plant sources are compatible with good health.
  • The lower bounds for infants and young children are higher (30 E%) due to their unique developmental and energy requirements.

8.8. Future Directions

Future updates to dietary reference values for fats may incorporate several developments:

  • Greater harmonisation of life‑stage groups and methodologies between EFSA, NNR, and other authorities (Allen et al., 2020, as cited in Nordic Council of Ministers, 2023).
  • Integration of environmental sustainability into quantitative recommendations, as already initiated by NNR2023, which recommends shifting from animal fats to plant‑based unsaturated oils to reduce greenhouse gas emissions and land use (Nordic Council of Ministers, 2023; Lovegrove, 2025).
  • More precise dose–response analyses using individual participant data (IPD) meta‑analyses and substitution modelling to better quantify the effects of replacing one macronutrient with another.
  • Refinement of age‑specific norms based on new evidence from diverse populations, including low‑ and middle‑income countries where traditional dietary patterns differ from those in Europe and North America.

In conclusion, the quantitative norms for dietary lipid intake are scientifically robust but context‑dependent. They provide a flexible framework for planning healthy diets at the population level, while recognising that individual needs vary. The core principles – limit saturated and trans fats, ensure adequate intake of essential polyunsaturated fatty acids, adjust total fat intake according to physical activity, and prioritise fat quality over strict quantity – remain valid and are consistently supported by the best available evidence.

References

  1. Carson, J.A.S., Lichtenstein, A.H., Anderson, C.A.M., Appel, L.J., Kris-Etherton, P.M., Meyer, K.A., Petersen, K., Polonsky, T. and Van Horn, L. (2020) ‘Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association’, Circulation, 141(3), pp. e39–e53. DOI: 10.1161/CIR.0000000000000743 PubMed
  2. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010) ‘Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol’, EFSA Journal, 8(3), p. 1461. DOI: 10.2903/j.efsa.2010.1461
  3. Herforth, A., Arimond, M., Alvarez-Sanchez, C., Coates, J., Christianson, K. and Muehlhoff, E. (2019) ‘A Global Review of Food-Based Dietary Guidelines’, Advances in Nutrition, 10(4), pp. 590–605. DOI: 10.1093/advances/nmy130 PubMed
  4. Hooper, L., Martin, N., Jimoh, O.F., Kirk, C., Foster, E. and Abdelhamid, A.S. (2020) ‘Reduction in saturated fat intake for cardiovascular disease’, Cochrane Database of Systematic Reviews, 2020(8), p. CD011737. DOI: 10.1002/14651858.CD011737.pub3 PubMed
  5. Kim, Y., Je, Y. and Giovannucci, E.L. (2021) ‘Association between dietary fat intake and mortality from all-causes, cardiovascular disease, and cancer: A systematic review and meta-analysis of prospective cohort studies’, Clinical Nutrition, 40(3), pp. 1060–1070. DOI: 10.1016/j.clnu.2020.07.007 PubMed
  6. Lenighan, Y.M., McNulty, B.A. and Roche, H.M. (2019) ‘Dietary fat composition: replacement of saturated fatty acids with PUFA as a public health strategy, with an emphasis on α-linolenic acid’, Proceedings of the Nutrition Society, 78(2), pp. 234–245. DOI: 10.1017/S0029665118002793 PubMed
  7. Lovegrove, J.A. (2025) ‘Dietary fats and cardiometabolic health-from public health to personalised nutrition: 'One for all' and 'all for one'’, Nutrition Bulletin, 50, pp. 132–141. DOI: 10.1111/nbu.12722 PubMed
  8. Ma, Y., Zhang, Z., Zhang, L., Wang, H., Chen, L. and Liu, L. (2024) ‘Dietary Macronutrient Intake and Cardiovascular Disease Risk and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies’, Nutrients, 16(1), p. 152. DOI: 10.3390/nu16010152 PubMed
  9. Mozaffarian, D. (2016) ‘Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review’, Circulation, 133(2), pp. 187–225. DOI: 10.1161/CIRCULATIONAHA.115.018585 PubMed
  10. Nordic Council of Ministers (2023) Nordic Nutrition Recommendations 2023. Copenhagen: Nordic Council of Ministers. DOI: 10.6027/nord2023-003
  11. Retterstøl, K. and Rosqvist, F. (2024) ‘Fat and fatty acids - a scoping review for Nordic Nutrition Recommendations 2023’, Food & Nutrition Research, 68, p. 9980. DOI: 10.29219/fnr.v68.9980 PubMed
  12. Rosqvist, F. and Niinistö, S. (2024) ‘Fats and oils – a scoping review for Nordic Nutrition Recommendations 2023’, Food & Nutrition Research, 68, p. 9979. DOI: 10.29219/fnr.v68.10487 PubMed
  13. Sacks, F.M., Lichtenstein, A.H., Wu, J.H.Y., Appel, L.J., Creager, M.A., Kris-Etherton, P.M., Miller, M., Rimm, E.B., Rudel, L.L., Robinson, J.G., Stone, N.J. and Van Horn, L.V. (2017) ‘Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association’, Circulation, 136(3), pp. e1–e23. DOI: 10.1161/CIR.0000000000000510 PubMed
  14. Schwingshackl, L., Zähringer, J., Beyerbach, J., Werner, S.S., Nagavci, B., Heseker, H., Koletzko, B. and Meerpohl, J.J. (2021) ‘A Scoping Review of Current Guidelines on Dietary Fat and Fat Quality’, Annals of Nutrition and Metabolism, 77, pp. 65–82. DOI: 10.1159/000515671 PubMed
  15. World Health Organization (WHO) (2023) Total fat intake for the prevention of unhealthy weight gain in adults and children: WHO guideline. Geneva: World Health Organization. ISBN 978-92-4-007365-4. Available at: https://www.who.int/publications/i/item/9789240073654.